𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor targeting of baculovirus displaying a lymphatic homing peptide

✍ Scribed by Anna R. Mäkelä; Juulia Enbäck; Johanna P. Laakkonen; Maija Vihinen-Ranta; Pirjo Laakkonen; Christian Oker-Blom

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
519 KB
Volume
10
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Tumor‐associated cells and vasculature express attractive molecular markers for site‐specific vector targeting. To attain tumor‐selective tropism, we recently developed a baculovirus vector displaying the lymphatic homing peptide LyP‐1, originally identified by ex vivo/in vivo screening of phage display libraries, on the viral envelope by fusion to the transmembrane anchor of vesicular stomatitis virus G‐protein.

Methods

In the present study, we explored the specificity and kinetics of viral binding and internalization as well as in vivo tumor homing of the LyP‐1 displaying virus to elucidate the applicability of baculovirus for targeted therapies.

Results

We demonstrated that the LyP‐1 peptide contributes to saturable binding of baculovirus in human MDA‐MB‐435 and HepG2 carcinoma cells and escalates the kinetics of viral internalization leading to earlier nuclear accumulation and enhanced transgene expression. The LyP‐1 displaying virus also showed stronger competitiveness against transduction with wild‐type baculovirus, suggesting involvement of a specific receptor in cellular attachment and entry. Following intravenous injections, the modified virus accumulated within the human MDA‐MB‐435 and MDA‐MB‐231 carcinoma xenografts in mice with higher specificity and efficiency than the control virus. Targeting of the modified virus was more specific in the MDA‐MB‐435 than in the MDA‐MB‐231 xenografts as demonstrated by higher tumor accumulation and lower distribution in nontarget organs. No apparent cytotoxicity was associated with the surface modification.

Conclusions

This first demonstration of in vivo tumor targeting of a systemically administered, tropism‐modified baculoviral vector highlights the potential of baculovirus‐mediated targeted therapies. Copyright © 2008 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Identification of a rhabdomyosarcoma tar
Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1
✍ Hendrik Witt; Katarina Hajdin; Kristina Iljin; Oliver Greiner; Felix K. Niggli; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 730 KB

## Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. To improve existing therapies and broaden the spectrum of cytotoxic agents that can be used in RMS treatment, we performed a phage‐display‐based screening for peptides that bind specifically to RMS cells. Two pep

Combinatorial discovery of tumor targeti
Combinatorial discovery of tumor targeting peptides using phage display
✍ Linda A. Landon; Susan L. Deutscher 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

## Abstract Peptides possess appropriate pharmacokinetic properties to serve as cancer imaging or therapeutic targeting agents. Currently, only a small number of rationally‐derived, labeled peptide analogues that target only a limited subset of antigens are available. Thus, finding new cancer targe

Suppression of tumor growth and metastas
Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library
✍ Ping An; Hetian Lei; Jianzhi Zhang; Shumei Song; Luowen He; Genglin Jin; Xiaoyin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 360 KB

## Abstract Although the VEGF‐Flk‐1‐pathway has been known as the major driving force of angiogenesis, new evidence has shown that VEGFR‐1/Flt‐1 plays important roles during the neovascularization under pathological conditions including tumor, atherosclerosis and arthritis. In search of Flt‐1 recep

αvβ3 Integrin-targeting of intraperitone
αvβ3 Integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
✍ Ingrid Dijkgraaf; John A.W. Kruijtzer; Cathelijne Frielink; Frans H.M. Corstens; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB

## Abstract Ovarian cancer is the fourth most common cause of cancer deaths among females in the western world after cancer of the breast, colon and lung. The inability to control the disease within the peritoneal cavity is the major cause of treatment failure in patients with ovarian cancer. The m